These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3958772)

  • 41. Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment.
    Herpst JM; Klein JL; Leichner PK; Quadri SM; Vriesendorp HM
    J Clin Oncol; 1995 Sep; 13(9):2394-400. PubMed ID: 7666099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma.
    Divgi CR; Scott AM; Gulec S; Broussard EK; Levy N; Young C; Capitelli P; Daghighian F; Williams JM; Finn RD
    Clin Cancer Res; 1995 Dec; 1(12):1503-10. PubMed ID: 9815950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent progress in the treatment of hepatocellular carcinoma.
    Roh MS
    Curr Opin Oncol; 1990 Aug; 2(4):725-30. PubMed ID: 1965691
    [No Abstract]   [Full Text] [Related]  

  • 44. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiferritin immunoglobulin therapy for treatment of hepatoma.
    Bucholtz JD; Powers G; Wall S
    Oncol Nurs Forum; 1988; 15(2):133-4. PubMed ID: 2451814
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of anti-ferritin antibody in the diagnosis and treatment of hepatocellular carcinoma].
    Liu KD
    Zhonghua Yi Xue Za Zhi; 1987 Nov; 67(11):621. PubMed ID: 2834028
    [No Abstract]   [Full Text] [Related]  

  • 47. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B; De Winter F; Defreyne L; Troisi R; Vanlangenhove P; Van Vlierberghe H; Lambert B; Praet M; de Hemptinne B; Dierckx RA
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Radioimmunoimaging (RII) and radioimmunotherapy (RIT) of human primary hepatic cancer (hPHC) with anti-PHC monoclonal antibody in tumor bearing nude mice].
    Shi L; Wu M; Chen H
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):20-3. PubMed ID: 7656780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cure of a mouse lymphoma with radio-iodinated antibody.
    Ghose T; Guclu A
    Eur J Cancer (1965); 1974 Dec; 10(12):787-92. PubMed ID: 4461282
    [No Abstract]   [Full Text] [Related]  

  • 50. 18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer.
    Risse JH; Pauleit D; Bender H; Rabe C; Fischer HP; Biersack HJ; Bucerius J
    Cancer Biother Radiopharm; 2009 Aug; 24(4):445-52. PubMed ID: 19694579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
    Novell JR; Hilson AJ
    J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
    [No Abstract]   [Full Text] [Related]  

  • 52. [The experimental study of anti-human AFP variant McAb in radioimmuno-detection and radioimmuno-therapy of human hepatocellular carcinoma model in nude mice].
    Liu Y; Wu MC; Qian GX
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):650-3. PubMed ID: 7539734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotherapy of cancer.
    Harris DT; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):180-98. PubMed ID: 2658082
    [No Abstract]   [Full Text] [Related]  

  • 54. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
    Launois B; Maddern G
    Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
    [No Abstract]   [Full Text] [Related]  

  • 55. [Possibility of radiotherapy of hepatic cancer by transcatheter arterial embolization with radioactive Lipiodol].
    Kobayashi H; Nakajo M; Shimabukuro K; Shirono K; Sakata H; Oyama T; Sonoda T; Shinohara S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jan; 44(1):96-8. PubMed ID: 6330667
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of 131I-labeled recombinant human tumor necrosis factor-alpha on the nude mice bearing human hepatoma].
    Long YH; Li YC; Mi YX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):787-92. PubMed ID: 19950584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma.
    Madsen MT; Park CH; Thakur ML
    J Nucl Med; 1988 Jun; 29(6):1038-44. PubMed ID: 2836572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radioimmunodetection of gastrointestinal neoplasms with antibodies to carcinoembryonic antigen.
    Hine KR; Bradwell AR; Reeder TA; Drolc Z; Dykes PW
    Cancer Res; 1980 Aug; 40(8 Pt 2):2993-6. PubMed ID: 7397694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiation enhancement of radiolabelled antibody deposition in tumors.
    Msirikale JS; Klein JL; Schroeder J; Order SE
    Int J Radiat Oncol Biol Phys; 1987 Dec; 13(12):1839-44. PubMed ID: 3679921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials.
    Chen ZN; Mi L; Xu J; Song F; Zhang Q; Zhang Z; Xing JL; Bian HJ; Jiang JL; Wang XH; Shang P; Qian AR; Zhang SH; Li L; Li Y; Feng Q; Yu XL; Feng Y; Yang XM; Tian R; Wu ZB; Leng N; Mo TS; Kuang AR; Tan TZ; Li YC; Liang DR; Lu WS; Miao J; Xu GH; Zhang ZH; Nan KJ; Han J; Liu QG; Zhang HX; Zhu P
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):435-44. PubMed ID: 16690431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.